Why AbCellera Biologics Stock Jumped 7% on Wednesday

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 15 September, 2021 by The TZ Newswire Staff

Why AbCellera Biologics Stock Jumped 7% on Wednesday

Shares of AbCellera Biologics (NASDAQ: ABCL) closed 7.1% higher today following news of a new partnership with Moderna (NASDAQ: MRNA), one of the first names to develop an effective COVID-19 vaccine.

See also
- Next Article UK and Trinidad health officials refute Nicki Minaj’s ‘false claim’ Covid shots cause swollen testicles
- Previous Article China’s US embassy says US, UK, Australia should ‘shake off’ their cold-war mentality
Editorial Calender

September 2021

M T W T F S S

1 2 3 4 5

6 7 8 9 10 11 12

13 14 15 16 17 18 19

20 21 22 23 24 25 26

27 28 29 30

« Aug Oct »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 15 September, 2021 by The TZ Newswire Staff

Why AbCellera Biologics Stock Jumped 7% on Wednesday

See also

Editorial Calender

Recent Tags